Skip to main content

Table 10 ADMET properties prediction of newly engineered compounds

From: In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations

Compounds

Absorption

Distribution

Metabolism

Excretion

Toxicity

Intestinal absorption

(human)

VDss

(human)

BBB permeability

CNS permeability

Substrate

Inhibitor

Total

Clearance

AMES toxicity

CYP

2D6

3A4

1A2

2C19

2C9

2D6

3A4

Numeric (%

Absorbed)

Numeric

(Log L/kg)

Numeric (Log BB)

Numeric (Log PS)

Categorical (Yes/No)

Numeric

(Log ml/min/kg)

Categorical (Yes/No)

C33

84.965

-0.376

-0.91

-2.442

No

Yes

No

No

Yes

No

Yes

-0.041

Not toxic

C34

85.861

-0.244

-0.872

-2.286

No

Yes

No

No

Yes

No

Yes

0.045

Not toxic

C35

78.69

-0.196

-0.917

-2.882

No

Yes

No

No

No

No

Yes

0.667

Not toxic

C36

79.355

-0.455

-1.123

-2.342

No

Yes

No

Yes

Yes

No

Yes

-0.184

Not toxic

C37

79.418

-0.447

-1.123

-2.344

No

Yes

No

Yes

Yes

No

Yes

-0.125

Not toxic

C38

79.526

-0.535

-1.006

-2.544

No

Yes

No

No

Yes

No

Yes

0.389

Not toxic

C39

79.588

-0.529

-1.006

-2.547

No

Yes

No

No

Yes

No

Yes

0.414

Not toxic

C40

71.147

-0.025

-0.904

-2.896

No

No

No

No

No

No

No

0.553

Not toxic

C41

77.503

-0.051

-0.709

-2.692

No

No

No

No

No

No

No

0.765

Not toxic

C42

77.44

-0.056

-0.709

-2.694

No

No

No

No

No

No

No

0.575

Not toxic